Cannabidiol <i>in vivo</i> blunts β‐amyloid induced neuroinflammation by suppressing IL‐1β and iNOS expression

Abstract

The results of the present study confirm in vivo anti-inflammatory actions of CBD, emphasizing the importance of this compound as a novel promising pharmacological tool capable of attenuating Abeta evoked neuroinflammatory responses.